CDK4/6 INHIBITOR

Clinical trials for CDK4/6 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new CDK4/6 INHIBITOR trials appear

Sign up with your email to follow new studies for CDK4/6 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Researchers track why breast cancer sometimes comes back after powerful drugs

Knowledge-focused Recruiting now

This study aims to understand why some early-stage breast cancers return after patients finish treatment with specific drugs called CDK4/6 inhibitors. Researchers will follow 750 patients who have taken these drugs to see who relapses and analyze their medical details. The goal i…

Matched conditions: CDK4/6 INHIBITOR

Sponsor: European Institute of Oncology • Aim: Knowledge-focused

Last updated Mar 19, 2026 14:56 UTC

CDK4/6 INHIBITOR

Get alerted when new CDK4/6 INHIBITOR trials appear

Researchers track why breast cancer sometimes comes back after powerful drugs